Covid symptoms have largely stayed the same over the last few years: cough, congestion, fever, a sore throat, nausea, ...

Shares of the battered biotech Vir Biotechnology were up more than 70% on Wednesday, as the company reported its first ...

InflaRx N.V. IFRX shares gained 7.7% on Wednesday following the European Commission's (EC) approval of marketing ...

A detailed examination of how patients respond to the drug at various times and doses provides greater context to a recent ...

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases.

When virologists took their first peek at XEC, the Covid-19 variant which started to become dominant in the autumn of 2024, ...

Patients with multiple myeloma (MM) can experience diminished immune responses during prolonged treatment; however, mRNA ...

“We are about five years into the pandemic, and yet there are not yet any federally-approved treatments for long Covid,” ...

The first severe human case of bird flu was recently reported in the U.S. Here are some ways the U.S. may be repeating the ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

New findings from the NIH RECOVER Initiative suggest that SARS-CoV-2 infection may be associated with an increased risk of ME ...

General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, “Toripalimab has made significant strides in its internationalization. As of today, toripalimab has been approved in 35 countries ...